Inventor · Welwyn Garden City, GB

Rene Robert Devos

12Patents
9h-index
14Co-inventors
69Inventor score

Filing activity: Sep 16, 1992 → Apr 12, 2013

Most-cited inventions

PatentTitleAreaCited byStatus
US6784166B2 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication. Emerging Cross-Sectional Technologies 138 Expired
US6660721B2 Anti-HCV nucleoside derivatives Human Necessities 128 Expired
US6025325A Pegylated obese (ob) protein compositions Chemistry; Metallurgy 51 Expired
US7608601B2 4′-Substituted nucleoside derivatives as inhibitors of HCV RNA replication Emerging Cross-Sectional Technologies 43 Expired
US8071567B2 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication Emerging Cross-Sectional Technologies 42 Active
US7915232B2 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication Emerging Cross-Sectional Technologies 25 Active
US5968779A Recombinant obese (ob) proteins Chemistry; Metallurgy 13 Expired
US5712121A Chimeric interleukin 5-receptor/immunoglobulin polypeptides Chemistry; Metallurgy 13 Expired
US6025324A Pegylated obese (ob) protein compositions Human Necessities 9 Expired
US5455337A DNA encoding chimeric polypeptides comprising the interleukin-5 receptor .alpha.-chain fused to immunoglobulin heavy chain constant regions Chemistry; Metallurgy 7 Expired
US5668256A Chimeric interleukin 5-receptor/immunoglobulin polypeptides Chemistry; Metallurgy 4 Expired
US8648054B2 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.